Crizotinib in Anaplastic Large-Cell Lymphoma
作者： Carlo Gambacorti-Passerini , Cristina Messa , Enrico M. Pogliani
DOI: 10.1056/NEJMC1013224
关键词:
摘要: … Crizotinib, an inhibitor of the anaplastic lymphoma kinase (ALK) tyrosine kinase, is active in … We treated two patients who had relapsed ALK-positive ALCL with crizotinib at a dose of 250 …
sci-hub.se 参考文章(2)
Roberto Chiarle, Claudia Voena, Chiara Ambrogio, Roberto Piva, Giorgio Inghirami, The anaplastic lymphoma kinase in the pathogenesis of cancer Nature Reviews Cancer. ,vol. 8, pp. 11- 23 ,(2008) , 10.1038/NRC2291
Eunice L. Kwak, Yung-Jue Bang, D. Ross Camidge, Alice T. Shaw, Benjamin Solomon, Robert G. Maki, Sai-Hong I. Ou, Bruce J. Dezube, Pasi A. Jänne, Daniel B. Costa, Marileila Varella-Garcia, Woo-Ho Kim, Thomas J. Lynch, Panos Fidias, Hannah Stubbs, Jeffrey A. Engelman, Lecia V. Sequist, WeiWei Tan, Leena Gandhi, Mari Mino-Kenudson, Greg C. Wei, S. Martin Shreeve, Mark J. Ratain, Jeffrey Settleman, James G. Christensen, Daniel A. Haber, Keith Wilner, Ravi Salgia, Geoffrey I. Shapiro, Jeffrey W. Clark, A. John Iafrate, Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer The New England Journal of Medicine. ,vol. 363, pp. 1693- 1703 ,(2010) , 10.1056/NEJMOA1006448